Analysis of Perfumes With SPME and High-Speed GC-TOFMS

Importance of the Topic

Indoor air quality has a direct impact on human health, particularly in enclosed environments where volatile organic compounds emitted by fragrances can accumulate. The presence of unlabeled allergens in perfume products contributes to sick building syndrome and allergy development in sensitive individuals.

Objectives and Study Overview

This work aimed to establish a rapid screening approach for identifying and comparing the volatile organic compounds released by three commercial perfume samples. The study focused on headspace analysis using solid phase microextraction and high-speed gas chromatography with time-of-flight mass spectrometry.

Methodology

Static headspace sampling of each perfume was performed by adding 1 mL of sample to a 20 mL vial. An automated SPME fiber injector collected the volatiles at 30 °C. A low-thermal-mass column enabled very fast temperature ramps, allowing full separation of compounds in under two minutes. Mass spectra were acquired at 50 spectra per second over a 40–350 u range.

Used Instrumentation

• Gas chromatograph: Agilent 6890 with low-thermal-mass column module
• Column: Rtx-5, 2 m × 0.18 mm id × 0.2 μm film
• Carrier gas: Helium at 3.0 mL/min constant flow
• Injection: SPME with 75 µm Carboxen-PDMS fiber, equilibration at 30 °C, 2 min extraction, 0.25 min desorption
• Mass spectrometer: LECO Pegasus III GC-TOFMS, EI 70 eV, source 200 °C, transfer line 250 °C, solvent delay 5.5 s
• Autosampler and control: CombiPAL autosampler and ChromaTOF software
• Oven program: 30 °C isothermal for 0.2 min, ramp to 250 °C at 200 °C/min, hold at 250 °C

Main Results and Discussion

All three samples contained a series of terpenes and oxygenates. Limonene was the dominant component, accounting for 59–70 % of total area in each sample. Other common compounds included α-pinene, camphene, myrcene, 4-carene, benzene methyl derivatives, and various cyclohexene isomers. High acquisition rates and spectral deconvolution allowed clear identification even during coelution.

Using one sample as a reference, the ChromaTOF Compare feature rapidly classified peaks in the other two samples as matches, out-of-tolerance, not found, or unknown. Only two compounds consistently matched the reference at predefined tolerances, demonstrating the utility of automated comparison for quality control and profiling.

Practical Benefits and Applications

• Minimal sample preparation with fully automated headspace SPME
• Rapid analysis cycle with sub-two-minute chromatography
• High spectral fidelity for accurate compound identification
• Automated comparison workflow for batch screening and QC

Future Trends and Potential Applications

• Integration of quantitative calibration standards for absolute concentration data
• Application of multidimensional GC-TOFMS for enhanced separation of complex fragrances
• Development of chemometric and machine learning tools for fingerprinting and source apportionment
• Expansion into real-time monitoring of indoor air and wearable sensors
• Linking VOC profiles to health impact assessments and regulatory standards

Conclusion

The combination of SPME headspace sampling, a low-thermal-mass GC column, and a high-speed TOFMS detector provides a powerful platform for rapid profiling of volatile fragrance components. Automated data processing with spectral comparison enables efficient identification of common and unique compounds across multiple samples, supporting applications in indoor air quality assessment and product quality control.

References

• eartheasy.com article on fragrance allergens
• United States Environmental Protection Agency. Sick building syndrome. Air and Radiation, Indoor Air Facts, 4. 1991.
• Redlich CA, Sparer J, Cullen MR. Sick-building syndrome. Lancet 1997;349(9057):1013-1016.
• Tsacoyianis R. Indoor air pollutants and sick building syndrome: a case study and implications for the community health nurse. Public Health Nursing 1997;14(1):58-75.
• Horvath EP. Building-related illness and sick building syndrome: from the specific to the vague. Cleveland Clinic Journal of Medicine 1997;64(6):303-309.
• Chester AC, Levine PH. Concurrent sick building syndrome and chronic fatigue syndrome: epidemic neuromyasthenia revisited. Clinical Infectious Diseases 1994;18(Suppl 1):S43-48.
• Ohm M, Juto JE, Andersson K, Bodin L. Nasal histamine provocation of tenants in a sick-building residential area. American Journal of Rhinology 1997;11(2):167-175.
• Bourbeau J, Brisson C, Allaire S. Prevalence of the sick building syndrome symptoms in office workers before and six months and three years after being exposed to a building with an improved ventilation system. Occupational and Environmental Medicine 1997;54(1):49-53.